Covalent modification by isoprenoid lipids, a process termed prenylation, is an important component in the localization and activity of many proteins involved in signal transduction pathways. The discovery that the members of the Ras family of oncogene products were modified by the farnesyl (15-carbon) prenyl group, and that prenylation was required for the Ras protein to express their transforming potential, has revealed a previously unrecognized mechanism for regulation of cell growth. Furthermore, a number of other proteins that play critical roles in cellular signaling processes have also been found to be subject to this processing, and a variety of studies have highlighted the importance of the attached isoprenoid in the function of these proteins. These findings have in turn led to the targeting of the enzymes responsible for these modifications in development of therapeutics against a variety of pathologies, mostly notably cancer. The long term goal of this research project is to elucidate the molecular mechanisms of protein prenylation. The primary routes to achieve this goal initially involved identification and cloning of the two main protein prenyltransferases, termed protein farnesyltransferase (FTase) and protein geranylgeranyltransferase type I (GGTase-I), involved in this processing. The work has now moved into detailed mechanistic and structure-function studies on these enzymes. The focus of this project over the next 5 years will be on deciphering the molecular basis for the specificities and catalytic properties of the two enzymes using a combination of molecular biological, biochemical, and structural approaches. In addition, the cloning and molecular analysis of a recently-identified enzyme apparently involved in the metabolism of prenyl proteins will be undertaken. Elucidation of the molecular and mechanistic details of protein prenylation should provide valuable information for the design and development of inhibitors of the enzymes involved as potential chemotherapeutic agents. Additionally, the information obtained in these studies will define experimental systems that should greatly facilitate future investigations into protein prenylation and the role of this process in cellular signaling events and oncogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM046372-05A1
Application #
2614286
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1993-08-01
Project End
2002-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Duke University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Mizrahi, Ariel; Berdichevsky, Yevgeny; Casey, Patrick J et al. (2010) A prenylated p47phox-p67phox-Rac1 chimera is a Quintessential NADPH oxidase activator: membrane association and functional capacity. J Biol Chem 285:25485-99
Cushman, Ian; Casey, Patrick J (2009) Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration. J Biol Chem 284:27964-73
Peterson, Yuri K; Wang, Xiang S; Casey, Patrick J et al. (2009) Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation. J Med Chem 52:4210-20
Ugolev, Yelena; Berdichevsky, Yevgeny; Weinbaum, Carolyn et al. (2008) Dissociation of Rac1(GDP).RhoGDI complexes by the cooperative action of anionic liposomes containing phosphatidylinositol 3,4,5-trisphosphate, Rac guanine nucleotide exchange factor, and GTP. J Biol Chem 283:22257-71
Katadae, Maiko; Hagiwara, Ken'ichi; Wada, Akimori et al. (2008) Interacting targets of the farnesyl of transducin gamma-subunit. Biochemistry 47:8424-33
Rao, P Vasantha; Peterson, Yuri K; Inoue, Toshihiro et al. (2008) Effects of pharmacologic inhibition of protein geranylgeranyltransferase type I on aqueous humor outflow through the trabecular meshwork. Invest Ophthalmol Vis Sci 49:2464-71
Leow, Jo-Lene; Baron, Rudi; Casey, Patrick J et al. (2007) Quantitative structure-activity relationship (QSAR) of indoloacetamides as inhibitors of human isoprenylcysteine carboxyl methyltransferase. Bioorg Med Chem Lett 17:1025-32
Sjogren, Anna-Karin M; Andersson, Karin M E; Liu, Meng et al. (2007) GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer. J Clin Invest 117:1294-304
Baron, Rudi A; Peterson, Yuri K; Otto, James C et al. (2007) Time-dependent inhibition of isoprenylcysteine carboxyl methyltransferase by indole-based small molecules. Biochemistry 46:554-60
Svensson, Annika W; Casey, Patrick J; Young, Stephen G et al. (2006) Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function. Methods Enzymol 407:144-59

Showing the most recent 10 out of 57 publications